Format

Send to

Choose Destination
Clin Rev Allergy. 1992 Spring-Summer;10(1-2):1-12.

Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes.

Author information

1
Department of Pediatrics, University of Michigan, Ann Arbor 48109-2029.

Abstract

IVIG is the definitive therapy for primary immunodeficiency diseases associated with hypogammaglobulinemia or specific antibody deficiencies. Administration of IVIG is relatively safe, but occasional adverse reactions are usually self-limited and generally are not an indication for stopping therapy. Home administration of IVIG has found increasing favor among treating physicians and their patients.

PMID:
1606517
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center